文献
J-GLOBAL ID:201702241034722862
整理番号:17A1953796
骨髄異形成症候群患者におけるWT1ペプチド癌ワクチンWT4869の第1/2相研究
Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome
著者 (9件):
Ueda Yasunori
(Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan)
,
Ogura Michinori
(Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan)
,
Miyakoshi Shigesaburo
(Department of Hematology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan)
,
Suzuki Takahiro
(Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan)
,
Heike Yuji
(Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan)
,
Tagashira Shuzo
(Sumitomo Dainippon Pharma, Tokyo, Japan)
,
Tsuchiya Satoru
(Sumitomo Dainippon Pharma, Tokyo, Japan)
,
Ohyashiki Kazuma
(Department of Hematology, Tokyo Medical University, Tokyo, Japan)
,
Miyazaki Yasushi
(Department of Hematology, Nagasaki University, Nagasaki, Japan)
資料名:
Cancer Science (Web)
(Cancer Science (Web))
巻:
108
号:
12
ページ:
2445-2453
発行年:
2017年
JST資料番号:
U0505A
ISSN:
1349-7006
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)